Supplementary Table S1 from FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma
Year: 2024
Type: supplementary-materials
Abstract: Supplementary Table S1. Baseline patient and disease characteristics.
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4396543751
